 "Torrent Pharma slips on disappointing Q2 results")
Torrent Pharmaceuticals has slipped 11% to Rs 1,400 on the BSE in an intra-day trade after the company reported a 59% year on year (YoY) drop in net profit at Rs 207 crore for the second quarter ended September 30, 2016 (Q2FY17), due to lower revenues. The drug maker had profit of Rs 509 crore in the same quarter year ago.
Total income from operations declined 15.6% to Rs 1,429 crore against Rs 1,693 crore in the corresponding quarter of previous fiscal.
The company’s US business more than halved to Rs 322 crore in Q2FY17 from Rs 712 crore in Q2FY16.
Torrent Pharma clarified that the previous period included exceptional revenues and profit which was primarily on account of the launch of a new product launch in the US market that had limited competition.
EBITDA (earnings before interest, taxes, depreciation, and amortization) margin declined to 26% from 46.5%.
At 11:34 am, the stock was down 9% at Rs 1,424 on the BSE, against 0.47% decline in S&P BSE Sensex. A combined 699,123 shares changed hands on the counter on BSE and NSE.
Total income from operations declined 15.6% to Rs 1,429 crore against Rs 1,693 crore in the corresponding quarter of previous fiscal.
The company’s US business more than halved to Rs 322 crore in Q2FY17 from Rs 712 crore in Q2FY16.
Torrent Pharma clarified that the previous period included exceptional revenues and profit which was primarily on account of the launch of a new product launch in the US market that had limited competition.
EBITDA (earnings before interest, taxes, depreciation, and amortization) margin declined to 26% from 46.5%.
At 11:34 am, the stock was down 9% at Rs 1,424 on the BSE, against 0.47% decline in S&P BSE Sensex. A combined 699,123 shares changed hands on the counter on BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%